Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 3
1984 1
1987 2
1988 3
1989 2
1991 2
1992 3
1993 2
1994 4
1995 3
1996 1
1997 3
1998 3
1999 2
2000 6
2001 1
2002 2
2003 4
2004 6
2005 4
2006 4
2007 6
2008 6
2009 1
2010 5
2011 3
2012 3
2013 8
2014 9
2015 8
2016 5
2017 8
2018 6
2019 11
2020 7
2021 11
2022 5
2023 8
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Sublethal cytochrome c release generates drug-tolerant persister cells.
Kalkavan H, Chen MJ, Crawford JC, Quarato G, Fitzgerald P, Tait SWG, Goding CR, Green DR. Kalkavan H, et al. Among authors: goding cr. Cell. 2022 Sep 1;185(18):3356-3374.e22. doi: 10.1016/j.cell.2022.07.025. Cell. 2022. PMID: 36055199 Free PMC article.
MITF-the first 25 years.
Goding CR, Arnheiter H. Goding CR, et al. Genes Dev. 2019 Aug 1;33(15-16):983-1007. doi: 10.1101/gad.324657.119. Epub 2019 May 23. Genes Dev. 2019. PMID: 31123060 Free PMC article. Review.
Pharmacological Targeting of STK19 Inhibits Oncogenic NRAS-Driven Melanomagenesis.
Yin C, Zhu B, Zhang T, Liu T, Chen S, Liu Y, Li X, Miao X, Li S, Mi X, Zhang J, Li L, Wei G, Xu ZX, Gao X, Huang C, Wei Z, Goding CR, Wang P, Deng X, Cui R. Yin C, et al. Among authors: goding cr. Cell. 2019 Feb 21;176(5):1113-1127.e16. doi: 10.1016/j.cell.2019.01.002. Epub 2019 Jan 31. Cell. 2019. PMID: 30712867 Free article.
Palmitoylation-dependent activation of MC1R prevents melanomagenesis.
Chen S, Zhu B, Yin C, Liu W, Han C, Chen B, Liu T, Li X, Chen X, Li C, Hu L, Zhou J, Xu ZX, Gao X, Wu X, Goding CR, Cui R. Chen S, et al. Among authors: goding cr. Nature. 2017 Sep 21;549(7672):399-403. doi: 10.1038/nature23887. Epub 2017 Sep 6. Nature. 2017. PMID: 28869973 Free PMC article.
An adverse tumor-protective effect of IDO1 inhibition.
Kenski JCN, Huang X, Vredevoogd DW, de Bruijn B, Traets JJH, Ibáñez-Molero S, Schieven SM, van Vliet A, Krijgsman O, Kuilman T, Pozniak J, Loayza-Puch F, Terry AM, Müller J, Logtenberg MEW, de Bruijn M, Levy P, Körner PR, Goding CR, Schumacher TN, Marine JC, Agami R, Peeper DS. Kenski JCN, et al. Among authors: goding cr. Cell Rep Med. 2023 Feb 21;4(2):100941. doi: 10.1016/j.xcrm.2023.100941. Cell Rep Med. 2023. PMID: 36812891 Free PMC article.
Single-cell profiling of MC1R-inhibited melanocytes.
Berns HM, Watkins-Chow DE, Lu S, Louphrasitthiphol P, Zhang T, Brown KM, Moura-Alves P, Goding CR, Pavan WJ. Berns HM, et al. Among authors: goding cr. Pigment Cell Melanoma Res. 2024 Mar;37(2):291-308. doi: 10.1111/pcmr.13141. Epub 2023 Nov 16. Pigment Cell Melanoma Res. 2024. PMID: 37972124
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation.
Li C, Wang Z, Yao L, Lin X, Jian Y, Li Y, Zhang J, Shao J, Tran PD, Hagman JR, Cao M, Cong Y, Li HY, Goding CR, Xu ZX, Liao X, Miao X, Cui R. Li C, et al. Among authors: goding cr. Nat Commun. 2024 Mar 9;15(1):2163. doi: 10.1038/s41467-024-46422-5. Nat Commun. 2024. PMID: 38461299 Free PMC article.
Acetylation reprograms MITF target selectivity and residence time.
Louphrasitthiphol P, Loffreda A, Pogenberg V, Picaud S, Schepsky A, Friedrichsen H, Zeng Z, Lashgari A, Thomas B, Patton EE, Wilmanns M, Filippakopoulos P, Lambert JP, Steingrímsson E, Mazza D, Goding CR. Louphrasitthiphol P, et al. Among authors: goding cr. Nat Commun. 2023 Sep 28;14(1):6051. doi: 10.1038/s41467-023-41793-7. Nat Commun. 2023. PMID: 37770430 Free PMC article.
162 results